- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 58001-44-8] Clavulanicacid
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-A0256 |
| Brand: | MCE |
| CAS: | 58001-44-8 |
Overview
| MDL | MFCD00867004 |
|---|---|
| Molecular Weight | 199.16 |
| Molecular Formula | C8H9NO5 |
| SMILES | O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)O |
3 Publications Citing Use of MCE
Summary
IC50 & Target
|
β-lactam
|
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT01015417 | Centre Hospitalier Universitaire, Amiens |
Acute Lithiasic Cholecystitis Grade I or II|Symptoms Lasting for Less Than 5 Days|Required Cholecystectomy|Preoperative Amoxicillin Clavulanic Acid for at Most 5 Days
|
May 2010 | Phase 3 |
| NCT02563769 | Temple University|National Institute on Drug Abuse (NIDA)|University of Pennsylvania |
Cocaine Dependence|Cocaine Addiction|Cocaine Abuse|Cocaine-Related Disorders
|
September 2016 | Phase 1 |
| NCT00656747 | Bayer |
Chronic Bronchitis
|
March 2008 | Phase 4 |
| NCT04400110 | IRCCS Burlo Garofolo |
Urinary Tract Infections
|
June 8, 2020 | Phase 4 |
| NCT01096927 | Maggiore Bellaria Hospital, Bologna |
Lower Abdominal Pain|Right Iliac Fossa Pain|Acute Appendicitis
|
January 2010 | Phase 4 |
| NCT00917592 | Consorci Sanitari de Terrassa|Corporacion Parc Tauli |
Diverticulitis
|
December 2005 | Phase 4 |
| NCT00495586 | Catalan Society of Family Medicine|Fondo de Investigacion Sanitaria |
Chronic Obstructive Pulmonary Disease
|
October 2007 | Phase 4 |
| NCT02571959 | Institut de Médecine et d´Epidémiologie Appliquée - Fondation Internationale Léon M´Ba |
Obesity
|
July 24, 2015 | Phase 1|Phase 2 |
| NCT03713424 | University of Missouri-Columbia |
Tobacco Use Disorder
|
March 26, 2019 | Phase 2 |
| NCT04980170 | Jordan University Hospital |
Antibiotics Causing Adverse Effects in Therapeutic Use
|
November 1, 2021 | Early Phase 1 |
| NCT05079620 | UConn Health |
Aspiration|Aspiration Pneumonia
|
November 30, 2021 | Phase 4 |
| NCT00665873 | Universita degli Studi di Catania |
Infections
|
January 2004 | Phase 4 |
| NCT03809312 | CHU de Quebec-Universite Laval |
Chronic Sinus Infection
|
August 14, 2019 | Phase 4 |
| NCT02007603 | Medical University of Vienna |
Infection During Hemodialysis
|
August 2013 | Phase 3 |
| NCT05562349 | Temple University|University of Pennsylvania Perelman School of Medicine|Medical University of South Carolina|Research Foundation for Mental Hygiene, Inc. |
Cocaine Dependence
|
October 2022 | Phase 2 |
| NCT04350502 | Centre Hospitalier Universitaire, Amiens |
Pleural Infection|Empyema|Community-acquired Pneumonia|Pharmacokinetic|Amoxicillin
|
April 4, 2020 | Not Applicable |
| NCT04411914 | Temple University|Beth Israel Deaconess Medical Center|University of Pennsylvania Perelman School of Medicine |
Cocaine Dependence
|
September 1, 2020 | Phase 1 |
| NCT03986762 | Temple University|National Institute on Drug Abuse (NIDA) |
Cocaine Dependence, in Remission|Cocaine Abuse, in Remission|Cocaine-Related Disorders
|
March 12, 2019 | Phase 1 |
| NCT02186951 | University Hospital, Limoges |
Ventilator-associated Pneumonia|Cardiac Arrests With Shockable Rhythm|Mild Therapeutic Hypothermia|Preventive Antibiotics
|
August 18, 2014 | Phase 3 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Solvent & Solubility
H 2 O : 50 mg/mL ( 251.05 mM ; Need ultrasonic)
DMSO : 13.89 mg/mL ( 69.74 mM ; ultrasonic and warming and heat to 60°C)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 5.0211 mL | 25.1054 mL | 50.2109 mL |
| 5 mM | 1.0042 mL | 5.0211 mL | 10.0422 mL |
| 10 mM | 0.5021 mL | 2.5105 mL | 5.0211 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 50 mg/mL (251.05 mM); Clear solution; Need ultrasonic
References
Synonyms
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.